Observations on the hormonal response of metastatic prostatic carcinoma
Forrest, J.B.
Journal of the Oklahoma State Medical Association 78(4): 104-105
1985
ISSN/ISBN: 0030-1876 PMID: 3998886 Document Number: 255977
Document emailed within 1 workday
Related Documents
Leewansangtong, S.; Soontrapa, S. 1999: Hormonal ablation therapy for metastatic prostatic carcinoma: a review Journal of the Medical Association of Thailand 82(2): 192-205Servadio, C. 1987: The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma Progress in Clinical and Biological Research 243b: 449-453
Ferraris, V.; Pacilli, N.; Bottero, G.; Novella, V.; Pisano, P.F.; Buffa, G. 1994: Treatment of prostatic carcinoma in clinical stage C. Comparison between radiotherapy plus hormonal therapy after progression and immediate hormonal therapy Minerva Urologica e Nefrologica 46(2): 123-128
Studer, U.E.; Altwein, J.; Bartsch, G. 1991: The potential hormonal therapy of prostatic carcinoma Der Urologe. Ausg. a 30(5): 310-316
Studer, U.E.; Münch, D. 1990: Hormonal therapy (medical orchiectomy) in prostatic carcinoma Schweizerische Medizinische Wochenschrift 120(24): 881-887
Barrack, E.R.; Brendler, C.B.; Walsh, P.C. 1987: Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment Progress in Clinical and Biological Research 243a: 79-97
Athens, A.T.; Grimaldi, A.M. 1983: Responses of metastatic prostatic carcinoma to endocrine therapy: report of a case Journal of the American Osteopathic Association 83(4): 307-311
Cicin-Sain, D.; Pasini, J. 1989: New possibilities in the hormonal therapy of metastatic carcinoma of the prostate Lijecnicki Vjesnik 111(11): 405-407
Strnad, V.; Riepl, M.; Kühn, R.; Sauer, R. 1996: Radiochemotherapy and simultaneous hormonal therapy of locally advanced prostatic carcinoma Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 172(4): 225-228
Izbicki, R.M.; Amer, M.H.; Al-Sarraf, M. 1979: Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase Ii study Cancer Treatment Reports 63(6): 999-1001
Maleeva, A.; Tsvetkov, M.; Kekhaĭova, M. 1980: Plasma testosterone: a sound criterion of the effectiveness of hormonal treatment of prostatic carcinoma Vutreshni Bolesti 19(3): 42-46
Cellini, N.; Luzi, S.; Morganti, A.G.; Balducci, M.; Caiazza, A.; Salvi, G.; Trodella, L.; Valentini, V. 1997: Neoadjuvant combined hormonal therapy and radiotherapy with external beam irradiation in prostatic carcinoma La Radiologia Medica 93(4): 446-450
Lo Re, G.; Buonadonna, A.; Duati, M.; Colussi, A.M.; Canzonieri, V.; Frustaci, S.; Morassut, S.; Cimitan, M.; Tumolo, S. 1999: Efficacy of total androgen blockade in metastatic prostatic carcinoma with transient hypogonadotropic hypogonadism: a case report Tumori 85(4): 280-283
Oelschläger, H.; Rothley, D.; Dunzendorfer, U. 1984: Plasma levels of fosfestrol and its monophosphate, of diethylstilbestrol and its monoglucuronide following intravenous administration in patients with metastatic prostatic carcinoma Arzneimittel-Forschung 34(10): 1333-1336
Katakkar, S.B.; Franks, C.R. 1978: Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate Cancer Treatment Reports 62(9): 1379-1380
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305
Pal, S.K.; Gartrell, B.; Olsson, C.A.; Stein, C.A. 2014: Metastatic adrenocortical carcinoma with a prolonged response to mitotane Oncology 28(7): 624
Lowe, F.C.; Isaacs, J.T. 1984: Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model Cancer Research 44(2): 744-752
Muss, H.B. 1988: The role of biological response modifiers in metastatic renal cell carcinoma Seminars in Oncology 15(5 Suppl 5: 30-34